JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

Anesth Analg 2008; 106:1784-1786
© 2008 International Anesthesia Research Society
doi: 10.1213/ane.0b013e318172fafc
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sichrovsky, T. C.
Right arrow Articles by Steinberg, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sichrovsky, T. C.
Right arrow Articles by Steinberg, J. S.

ANESTHETIC PHARMACOLOGY

Dexmedetomidine Sedation Leading to Refractory Cardiogenic Shock

Tina C. Sichrovsky, MD, Suneet Mittal, MD, and Jonathan S. Steinberg, MD

From the St. Luke's-Roosevelt Hospital Center/Columbia University, New York City, New York.

Address correspondence and reprint requests to Tina C. Sichrovsky, MD, St. Luke's-Roosevelt Hospital Center/Columbia University, 1111, Amsterdam Ave., New York City, NY 10025. Address e-mail to Tina.sichrovsky{at}gmx.net.

Dexmedetomidine is frequently used for deep sedation during electrophysiology procedures. We report a case where, presumably, the use of dexmedetomidine resulted in a patient's death. The patient developed unexplained and refractory cardiogenic shock and could not be resuscitated. Autopsy failed to demonstrate any abnormality or cause of death. We postulate that, in certain susceptible individuals, dexmedetomidine may lead to terminal complications. We therefore urge caution about using dexmedetomidine in the electrophysiology laboratory.




This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
G. W. Fischer and J. H. Silverstein
Dexmedetomidine and Refractory Cardiogenic Shock
Anesth. Analg., January 1, 2009; 108(1): 380 - 380.
[Full Text] [PDF]

Home page
 Anesth. Analg.Home page
T. C. Sichrovsky, S. Mittal, and J. S. Steinberg
Caution Is Necessary When Dexmedetomidine Is Used Off-Label, Especially When Combined with Other Sedatives
Anesth. Analg., January 1, 2009; 108(1): 381 - 382.
[Full Text] [PDF]

Home page
 Anesth. Analg.Home page
M. P. Hutchens and P. Thorborg
Dexmedetomidine Sedation (and Cardiac Perforation, Pericardial Tamponade, Cardiac Arrest, and Cardiopulmonary Resuscitation) Leading to Refractory Cardiogenic Shock
Anesth. Analg., January 1, 2009; 108(1): 379 - 380.
[Full Text] [PDF]

Home page
 Anesth. Analg.Home page
D. Stamenkovic, I. Kangrga, and M. Karanikolas
Caution Is Necessary When Dexmedetomidine Is Used Off-Label, Especially When Combined with Other Sedatives
Anesth. Analg., January 1, 2009; 108(1): 380 - 381.
[Full Text] [PDF]

Home page
 Anesth. Analg.Home page
P. O. Talke and M. Maze
Expecting the Unexpected
Anesth. Analg., June 1, 2008; 106(6): 1605 - 1606.
[Full Text] [PDF]


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2008 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2008 by the International Anesthesia Research Society.